At Vifor Pharma, we are dedicated to finding the right treatment solutions for patients. Over several decades, we have proven our ability to identify and serve therapeutic areas with significant unmet medical need, successfully building on our expertise and track record to create new markets.
www.viforpharma.com AMOUNT: 40.000 Euros
CSL Vifor supports the Nephro Update Europe 2025 as Partner.
CSL Vifor supports the Nephro Update Europe 2025 as Partner.
The MEDICE Health Family develops and distributes innovative, integrated and highly diverse healthcare solutions. Our aim is to develop suitable preventative and therapeutic concepts for every stage of an illness; from the initial onset through to chronic symptoms by integrating pharmaceutical, digital and nutritional medicine expertise and combining them together within an innovative preventative and therapeutic management system.
www.medice.com Medice supports the Nephro Update Europe 2025 as Partner.
Boehringer Ingelheim is driven by the desire to serve humankind by improving human and animal health. As a successful, family owned company BI plans in generations. They work together globally and with integrity.
www.boehringer-ingelheim.com Boehringer Ingelheim supports the Nephro Update Europe 2025 as Partner.
STADA is a leading manufacturer of high-quality pharmaceuticals. With a long-standing heritage rooted in pharmacies, we are perceived as a reliable and trustworthy partner for more than 125 years. With our proven Generics, we ensure that everyday health remains affordable.
www.stada.com Stada supports the Nephro Update Europe 2025 as Partner.
For more than 100 years, we have been translating the unmet medical needs of people living with a serious chronic disease into innovative medicines and delivery systems, like our insulin pens.
www.novonordisk.com Our treatments today are benefiting millions of people living with diabetes, obesity, and rare blood and endocrine diseases.
From our labs to our factory floors, we are discovering and developing innovative biological medicines and making them accessible to patients throughout the world.
Novo Nordisk supports the Nephro Update Europe 2025 as Partner.
